IBYRA 150MG TAB
Prescription Required
Couldn't load pickup availability

- Introduction
- Uses
- Storage
- Safety
- Side effects
- Abouts RareMeds
- Disclaimer
Introduction
Ibyra 150mg Tablet contains abemaciclib, a CDK4/6 inhibitor that slows the growth of hormone receptor-positive breast cancer cells.
Uses
Ibyra 150mg Tablet is used in combination with endocrine therapy for HR-positive, HER2-negative advanced or metastatic breast cancer.
Storage
- Store below 30°C in a cool, dry place.
- Protect from moisture.
Safety Information
- Monitor complete blood counts and liver function during treatment.
- Inform your doctor about diarrhoea, infections or liver disease.
Possible Side Effects
Possible side effects may include:
- Diarrhoea
- Fatigue
- Nausea
- Decreased appetite
- Low white blood cell count
- Infections
- Elevated liver enzymes
About RareMeds
We, at RareMeds, make a diligent attempt to deliver accurate, expert-drafted and thoroughly reviewed medicine-related information to our consumers. However, it should, by no means, be considered a substitute for a prescription from a certified doctor or a trustworthy doctor-patient relationship. In fact, we detest any form of self-medication without expert advice.
The sole purpose of the information on our portal is to educate our consumers, which helps improve communication between a doctor and a patient. The information is by no means complete in its entirety and should not be used to diagnose or treat any medical condition.
No amount of information can replace the experience and expertise of a doctor; therefore, his/her advice always holds priority and should be followed appropriately.
Disclaimer
Ibyra is a prescription anticancer medicine.
It should only be used under specialist oncology supervision.